Key note speakers

Professor Antonis Antoniou

Professor of Cancer Risk Prediction

Department of Public Health and Primary Care, University of Cambridge

Director, Centre for Cancer Genetic Epidemiology and Cancer Data-Driven Detection (CD3) Programme

Professor Antoniou is a genetic epidemiologist whose work has advanced understanding of the genetic basis of common cancers and the prediction of cancer risk prediction. His research focuses on developing and applying statistical modelling techniques to address clinically important questions. His work has provided widely used risk estimates for carriers of BRCA1, BRCA2, PALB2 and other cancer susceptibility genes. He leads the international Consortium of Modifiers of BRCA1/2 coordinating centre, which demonstrated that genetic modifiers significantly influence cancer risk for mutation carriers. He developed the BOADICEA and CanRisk models and led their implementation in the CanRisk tool (www.canrisk.org), which is used globally by clinicians to estimate multifactorial breast, ovarian and prostate cancer risk. He also directs the Cancer Data-Driven Detection (CD3, www.cd3.org) national strategic programme. His contributions have been recognised with the 2019 Basser Global Prize for pioneering BRCA1/2 research and the 2024 Don Listwin Award for contribution to cancer early detection. He was elected Fellow of the Academy of Medical Sciences in 2026.

__________________________________________________________________________________

Professor Karla Unger‑Saldaña

Assistant Professor

Health Promotion & Behavioral Sciences Department & Institute for Implementation Science, UTHealth Houston School of Public Health

More details to follow soon

__________________________________________________________________________________


Image courtesy of Wolfson Institute of

Population Health, Queen Mary University of London.

Professor Peter Sasieni

Professor of Cancer Epidemiology,

Centre Co-Lead for the Centre for Cancer Screening, Prevention and Early Diagnosis

Professor Peter Sasieni is an internationally recognised

leader in cancer prevention, screening and early detection. He is Professor of

Cancer Epidemiology at Queen Mary University of London, Co-Lead of the Centre

for Cancer Screening, Prevention and Early Diagnosis, and Director of the

Cancer Research UK Cancer Prevention Trials Unit.

With a distinguished career spanning mathematical

statistics, epidemiology and clinical trials, his research has made important

contributions to the evidence base for cancer screening and prevention. He

leads major national studies evaluating new approaches to cancer detection,

including the NHS-Galleri trial and the CRUK–NIHR-funded BEST4 platform.

He is a Fellow of the Academy of Medical Sciences and was

awarded the 2023 Don Listwin Award for Outstanding Contribution to Cancer Early

Detection, recognising his significant contribution to advancing the field.